Jurisdiction J (Cahaba)Transition to MolDx program

The MolDX team welcomes the states of Georgia, Tennessee, and Alabama to the MolDX program and to Palmetto GBA. Medicare part A and part B providers in the Palmetto GBA jurisdiction are required to register all molecular tests with the Diagnostics Exchange^TM (DEX), an online test registry. DEX Diagnostics Exchange^TM will assign a unique Z-Code identifier to each molecular test. After the registration and application processes have been completed, the MolDX team will access the registry information to determine if a test meets the Medicare criteria for coverage. The exact time when the DEX identifier will be required on claims has not been determined at this time. However, one should expect no later than March 1, 2018.

Source: https://www.palmettogba.com